Is MNKD a good stock to buy? We came across a bullish thesis on MannKind Corporation on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on MNKD. MannKind Corporation’s share was trading at $3.8400 as of June 24th. MNKD’s trailing and forward P/E were 178.00 and 40.49 respectively according to Yahoo Finance.
Sergey Nivens/Shutterstock.com
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming...
